(Q38114818)

29 August 2017

title

A composite scale applied to evaluate anxiety in schizophrenic patients (SAES). (English)

1 reference

29 August 2017

0 references

1

Pierre-Michel Llorca

1 reference

29 August 2017

5

Ludovic Samalin

1 reference

29 August 2017

2

Christophe Lancon

1 reference

29 August 2017

3

Olivier Blanc

1 reference

29 August 2017

Ingrid de Chazeron

4

1 reference

29 August 2017

Hervé Caci

series ordinal

6

1 reference

29 August 2017

Jean-Alexandre Lesturgeon

series ordinal

7

1 reference

29 August 2017

Franck J Bayle

series ordinal

8

1 reference

29 August 2017

publication date

15 June 2013

1 reference

European Archives of Psychiatry and Clinical Neuroscience

29 August 2017

published in

1 reference

29 August 2017

volume

264

1 reference

29 August 2017

issue

2

1 reference

29 August 2017

page(s)

171-178

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-013-0416-1

29 August 2017

exact match

0 references

cites work

How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Mechanisms of relapse prevention in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Social anxiety in outpatients with schizophrenia: a relevant cause of disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

The quality of life of the mentally ill living in residential facilities: findings from a national survey in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Can we harness computerised cognitive bias modification to treat anxiety in schizophrenia? A first step highlighting the role of mental imagery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Negative symptoms and concomitant attention deficits in schizophrenia: associations with prospective assessments of anxiety, social dysfunction, and avoidant coping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Anxiety disorders in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Quality of life in schizophrenia: contributions of anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Deficits in theory of mind and social anxiety as independent paths to paranoid features in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

An exploration of the psychometric properties of the French version of the Positive and Negative Syndrome Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Intraclass correlations: uses in assessing rater reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0416-1

[Efficacy of zuclopenthixol acetate on psychotic anxiety evaluated in an open study]

21 January 2018

1 reference

12 December 2020

Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol

1 reference

12 December 2020

Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial

1 reference

12 December 2020

A comprehensive psychopathological rating scale

1 reference

12 December 2020

Predictors of psychosis: a 50-year follow-up of the Lundby population

1 reference

12 December 2020

“Panic-like” symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: Observations and implications

1 reference

12 December 2020

[Pharmacological management of anxiety in patients suffering from schizophrenia]

1 reference

12 December 2020

[Tyrer's Brief Scale for Anxiety used with outpatients. First validation in the French language]

1 reference

12 December 2020

Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life

1 reference

12 December 2020

[Psychotic anxiety and neurotic anxiety. Qualitative or quantitative difference]

1 reference

12 December 2020

Effects of risperidone on affective symptoms in patients with schizophrenia

1 reference

12 December 2020

Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group

1 reference

12 December 2020

[Preliminary construction and validation of an anxiety scale derived from the French version of the AMDP, the AMDP-AT]

1 reference

12 December 2020

The Psychotic Anxiety Scale (PAS). Evaluation of inter-rater reliability and correspondence factorial analysis

1 reference

12 December 2020

Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms.

1 reference

12 December 2020

10.1007/S00406-013-0416-1

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1016619344

0 references

1 reference